RE:RE:RE:RE:Yea it is a gift I agree with this statement. One thing we must consider is what the alternative was...$0
At the end of the day, a company with a $3 million market cap raised $25 million and is now funded through to a registration study. They will now be able to dose a bunch of patients in combination with Keytruda and Incyte's drug.
it will be a bumpy road for a few weeks for sure. I just hope that they can mimic past results with a larger group size and perhaps start their OTS treatment. If they can demonstrate efficacy on a larger scale this will still be a big win.
they have been out of money for 18 months so it's at least a good thing that the lights are on and we can get back to doing what we did before.
$10 share price is )120 million market cap. These plays on the Nasdaq can easily float up to the $500 mill-$ 1 Bill valuation on a catalyst which is very possible here.
ive been around this name for many years now. Did some tax loss selling in dec but am back on the buy side now to take advantage of the current market mispricing. Clients sell the shares and keep the warrants or sell the warrants to lower cost base of the shares...why we see it trading below IPO price. It will take a bit of time to churn this out but it will happen.
Cheers,
Silky